Financials
- Market Capitalization 5.02 B
- Employee 838
- Founded 2014
- CEO Mark Crossley
- Website www.indivior.com
- Headquarter Delaware, United States
- FIGI BBG01ZTXFLQ6
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
15.63
ratio cours/chiffre d'affaires
3.02
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1131 | LNTH Lantheus Holdings, Inc. - Common Stock | 104.83 USD | +2.40% | -1.54% | -0.16% | +87.00% | 6.83 B USD | ||
| 1280 | AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.21 USD | +3.12% | +2.75% | +5.58% | +63.13% | 5.49 B USD | ||
| 1786 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 47.43 USD | +1.65% | -2.45% | +7.58% | -12.17% | 2.75 B USD | ||
| 1834 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.21 USD | -7.79% | -18.85% | -69.30% | -64.07% | 2.58 B USD |